Furloughed FDA staff have returned to work after the two-week government shutdown to face a backlog of submissions. Some in industry are anxious to hear how the agency plans to deal with the situation, particularly how the backlog will impact its ability to meet user-fee performance goals.
During the 16-day-long government shutdown, the agency continued to review device submissions made by companies prior to Oct. 1, with...